Amgen Stock Holds Steady Near Record High Amid Double-Digit Growth

Amgen stock is holding steady near its record high as of August 20, 2026, thanks to double-digit revenue growth in Q2 2026 and a steady dividend. The company reported that total revenues for the second quarter rose 10% to $10.1 billion compared with the same period in 2025.

This growth builds on Amgen's broader 2026 trajectory, signaling that the recent quarter represents a continuation of its expansion rather than a one-off spike. Investors tracking fundamentals can treat the $10.1 billion Q2 2026 revenue base as a current metric within the standard freshness window.

The company is also offering shareholders a quarterly cash dividend that goes ex-dividend on August 21, 2026. Shareholders of record on this date will receive a dividend of $2.52 per share, scheduled for payment on September 11, 2026.